MedPath

Therapeutic evaluation and efficacy of Regimenal modality (Dry Cupping)and Unani formulation (Asbi drug) in the management of Diabetic peripheral Neuropathy

Phase 2
Conditions
Health Condition 1: E114- Type 2 diabetes mellitus with neurological complications
Registration Number
CTRI/2024/04/065099
Lead Sponsor
Hakim Syed Ziaul Hasan Government Unani Medical College and College
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Patient with diabetes mellitus type 1 and type 2.stable blood glucose level less than 200mg/dl. that is HBsAg less than 9%

3. patients complain of pain in foot, burning and tingling sensation

Exclusion Criteria

1. patients less than 25 years and above 60 years

2.Pregnant and lactating women

3.History of malignancy and tumour.

4.Other causes of neuropathy

5.Any spinal diseases

6.Skin lesions or skin allergy

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Machigan neuropathy instrument <br/ ><br>Vibration perception thresholdTimepoint: 0 day and 30th day
Secondary Outcome Measures
NameTimeMethod
Pain in feet <br/ ><br>tingling and burning sensationTimepoint: every alternative days,for one month
© Copyright 2025. All Rights Reserved by MedPath